MARATTO

article · Journal of Asthma

Clinical utility of pentraxin-3 and eosinophil-derived neurotoxin as biomarkers of disease activity in pediatric bronchial asthma

Abstract

EDN and PTX3 are associated with pediatric asthma, reflecting different components of airway inflammation. EDN demonstrated closer relationships with markers of disease activity suggesting its potential role as an adjunct biomarker for monitoring inflammation, while PTX3 primarily differentiated asthmatic from healthy children. These biomarkers should be considered complementary research tools rather than stand-alone diagnostic tests.

Research topics

  • Biomarkers in Disease Mechanisms
  • Asthma and respiratory diseases
  • IL-33, ST2, and ILC Pathways

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/02770903.2026.2652315

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.